Cochlear Limited (ASX: COH) Share Price and News
Price
Movement
52 Week Range
1 Year Return
() Chart and Price Data
Cochlear Limited (ASX: COH) Latest News
2 of the best ASX healthcare shares to buy in 2021
James Mickleboro | December 24, 2020 7:35am
Cochlear (ASX:COH) share price edges higher despite losing US patent dispute appeal
James Mickleboro | December 15, 2020 10:35am
Recent Stock Announcements
| Date | Heading | An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. | Time | Pages | File Size |
|---|---|---|---|---|---|
About Cochlear Limited (ASX: COH)
Cochlear Limited (COH) is a global leader in implantable hearing devices. The company manufactures and distributes cochlear implantable devices for hearing impaired.
Based in Sydney, Cochlear has operations in more than 20 countries, distributing its products in America, Asia Pacific, Europe, the Middle East and Africa. It offers three main products: Cochlear implants, Baha bone conduction implants and Cochlear Wireless Accessories.
Cochlear was formed in 1981, with COH shares first listing on the ASX almost 15 years later in 1995. Since then, the Cochlear share price has risen exponentially and the company is now one of the largest-listed companies on the ASX.
Director Transactions
Data provided by Morningstar.Directors & Management
Data provided by Morningstar.Top Share Holders
Data provided by Morningstar.| Name | Shares | Capital |
|---|---|---|
| HSBC Custody Nominees (Australia) Limited | 28,405,386 | 43.24% |
| J P Morgan Nominees Australia Pty Limited | 11,371,030 | 17.31% |
| Citicorp Nominees Pty Limited | 4,113,509 | 6.26% |
| National Nominees Limited | 1,682,907 | 2.56% |
| BNP Paribas Noms Pty Ltd <DRP> | 1,540,107 | 2.34% |
| BNP Paribas Nominees Pty Ltd <Agency Lending DRP A/C> | 1,132,094 | 1.72% |
| HSBC Custody Nominees (Australia) Limited GSCO ECA | 738,643 | 1.12% |
| Australian Foundation Investment Company Limited | 323,715 | 0.49% |
| HSBC Custody Nominees (Australia) Limited (NT Comnwlth Super CORP) | 300,693 | 0.46% |
| Netwealth Investments Limited <Wrap Services A/C> | 231,860 | 0.35% |
| Citicorp Nominees Pty Limited <Colonial First State INV A/C> | 226,944 | 0.35% |
| Mr Christopher Graham Roberts | 162,173 | 0.25% |
| BNP Paribas Nominees Pty Ltd Hub24 Custodial Serv Ltd <DRP A/C> | 103,774 | 0.16% |
| PGA (Investments) Pty Ltd | 100,118 | 0.15% |
| National Nominees Limited <DB A/C> | 86,230 | 0.13% |
| AMP Life Limited | 79,421 | 0.12% |
| HSBC Custody Nominees (Australia) Limited A/C 2 | 71,519 | 0.11% |
| UBS Nominees Pty Ltd | 70,592 | 0.11% |
| Avanteos Investments Limited <Encircle IMA A/C> | 68,964 | 0.10% |
| Custodial Services Limited <Beneficiaries Holding A/C> | 67,214 | 0.10% |
FAQ
Will Cochlear pay a dividend in 2020?
Cochlear typically pays twice yearly dividends in April and October. Over the past five years, the company’s dividends have all been fully franked. Prior to this, Cochlear’s dividends varied between fully franked and partially franked with only one dividend over this time being 100% unfranked. Cochlear’s last interim dividend of $1.60 per share was paid on 17 April 2020. The medical devices company has an impressive dividend payment history dating back to 1997. In March 2020, however, Cochlear withdrew its FY20 earnings guidance and announced a capital raising to enhance its liquidity. This was following the negative impacts of COVID-19 on its revenue streams. It also announced suspension of the company’s dividend until trading conditions improve.
Does Cochlear offer a DRP?
At at 17 June 2020, Cochlear does not offer a dividend reinvestment plan.